Skip to content
Screener

Revolution Medicines, Inc. RVMD Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

BridgeBio Pharma logo
BridgeBio PharmaBBIO
$17.23M+140%
Erasca, Inc. logo
Erasca, Inc.ERAS
$28.27M-10.3%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$37.18M-13.0%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$370K+208%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$1.21M-32.7%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$2.49M-34.9%

Other financials

Income statement

See full
Revenue-
Operating income-$505.1M-90.8%
Net income-$644.4M-160%
EPS (diluted)-$3.06-134%

Balance sheet

See full
Cash & equivalents$815.4M+103%
Total debt$154.5M+16.3%
Total equity$2.6B+39.7%
Total assets$4.3B+77.9%

Cash flow

See full
Operating cash flow-$387.3M-74.7%
CapEx$2.3M-69.3%
Free cash flow-$389.6M-70.0%

Valuation

See full
Market cap$42.4B+521%
Enterprise value$41.74B+536%

Profitability

See full
Operating margin-88,031.9%-89,488pp
Net margin-76,423.3%-77,733pp
FCF margin-74,273.9%-75,457pp

Returns & leverage

See full
Return on equity-79.1%+182pp
Debt / equity0.1×0.0×
Current ratio11.4×-0.4×

Where this comes from

Reported directly by Revolution Medicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The source filing: Revolution Medicines, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:10 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335104
Line itemJune 30, 2026December 31, 2025
Prepaid expenses and other current assets90,36949,358
Total current assets4,028,3382,075,037
Property and equipment, net34,60833,194
Operating lease right-of-use asset127,844132,084
Intangible assets, net55,80055,800
Goodwill14,60814,608
Restricted cash4,8584,858
Long-term deposits42,45424,148

Item 1. Financial Statements.

FAQ

What is Revolution Medicines, Inc.'s operating lease ROU assets?
Revolution Medicines, Inc. (RVMD) reported operating lease ROU assets of $127.84M in Q2 2026.
How has Revolution Medicines, Inc.'s operating lease ROU assets changed year-over-year?
Revolution Medicines, Inc.'s operating lease ROU assets increased by 12.1% year-over-year, from $114M to $127.84M.
What is the long-term trend for Revolution Medicines, Inc.'s operating lease ROU assets?
Over 5 years (2020 to 2025), Revolution Medicines, Inc.'s operating lease ROU assets has grown at a 36.9% compound annual growth rate (CAGR), from $27.44M to $132.08M.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about Revolution Medicines, Inc.'s operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude